ArticleCell death discovery2025

Sibiriline, a novel dual inhibitor of necroptosis and ferroptosis, prevents RIPK1 kinase activity and (phospho)lipid peroxidation as a potential therapeutic strategy.

Claire Delehouzé et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.